Moderna is seeking a senior scientific leader to provide strategic and operational leadership for Toxicology and Pathology within Nonclinical Safety Evaluation. The role focuses on ensuring scientifically rigorous and compliant nonclinical safety strategies and data packages for regulatory submissions, particularly for products in Moderna's systemic IV portfolio (Autoimmune, Immuno-Oncology, Rare Disease) and novel technologies. This position involves leading a team, serving as a key scientific contributor in regulatory interactions, and driving scientific awareness both internally and externally.
Provide direct and matrix management to a high-performing team of Toxicologists and Pathologists.,Offer integrated strategic leadership for Toxicology and Pathology in nonclinical safety evaluation, spanning discovery to post-marketing.,Apply deep knowledge of how nonclinical safety disciplines integrate across the business.,Evaluate complex non-clinical safety challenges and develop innovative solutions.,Provide strategic oversight and guidance to team members on developing scientifically sound nonclinical safety strategies.,Accountable for the design, execution, critical analysis, and reporting of GLP/non-GLP nonclinical safety in vitro and/or in vivo studies.,May be responsible for toxicology assessments supporting extractable/leachable, contaminant risk, and impurity qualification.,Serve as a key scientific contributor in regulatory agency interactions, internal governance, and leadership meetings.,Utilize expert scientific and regulatory writing skills for authoring and reviewing submission documents (INDs, CTAs, BLAs, MAAs) and health authority interaction documents.,Oversee the preparation and presentation of nonclinical safety data for various stakeholders.,Maintain extensive scientific awareness through publications, conference presentations, and engagement with the scientific community.,Act as an independent contributor for selected discovery and/or pipeline programs as a Toxicology Lead.
PhD.,11 or more years overseeing aspects of nonclinical safety assessment activities in pharmaceutical development.,Experience in nucleic acid-based and nanoparticle modalities, immune-modulating therapeutics, oncology, and/or infectious disease vaccine drug development is strongly considered.,Experience serving in and/or managing colleagues in a Toxicology representative role on drug development programs.,Experience designing and executing nonclinical toxicology strategies and GLP/non-GLP studies.,Experience in mentoring, coaching, and/or managing others.,Experience applying regulatory guideline knowledge in nonclinical safety studies to support regulatory filings.,Direct experience writing, reviewing, and critiquing nonclinical sections of regulatory submission documents and interacting with regulatory agencies.
PhD
Must be a U.S. person (citizen, permanent resident, asylee, or refugee) due to U.S. export control laws.,Work in a smoke-free, alcohol-free, and drug-free environment.
Moderna is a biotechnology company pioneering a new class of medicines made of messenger RNA (mRNA). The company's platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and autoimmune diseases.
BerryMap uses cookies to provide essential features, analyze usage, and improve your experience. You can customize your preferences below.